Position in NBIX
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$306,405
-$97,905 QoQ
Shares Held
1,818
-40.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#536
of 768 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Navalign, LLC holds $745,397 across 2 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (41.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
6,109 | $438,992 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
1,818 | $306,405 |
All Filings in NBIX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $306,405 | 1,818 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $404,310 | 3,069 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $511,864 | 3,609 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $506,631 | 3,609 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||